Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Farmacogenética")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 4908

  • Page / 197
Export

Selection :

  • and

Bisphosphonates pathwayLI GONG; ALTMAN, Russ B; KLEIN, Teri E et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 1, pp 50-53, issn 1744-6872, 4 p.Article

Very important pharmacogene summary ADRB2LITONJUA, Augusto A; LI GONG; QING LING DUAN et al.Pharmacogenetics and genomics (Print). 2010, Vol 20, Num 1, pp 64-69, issn 1744-6872, 6 p.Article

Pharmacogenetics and geographical ancestry: implications for drug development and global healthDAAR, Abdallah S; SINGER, Peter A.Nature reviews. Genetics (Print). 2005, Vol 6, Num 3, pp 241-246, issn 1471-0056, 6 p.Article

A Population Pharmacokinetic-Pharmacogenetic Analysis of AtazanavirKILE, Deidre A; MAWHINNEY, Samantha; AQUILANTE, Christina L et al.AIDS research and human retroviruses. 2012, Vol 28, Num 10, pp 1227-1234, issn 0889-2229, 8 p.Article

PharmacogénétiqueLEBLANC, Thierry.Correspondances en onco-hématologie. 2014, Vol 9, Num 6, issn 1954-4820, [23 p.]Serial Issue

ABCB1 pharmacogenetics : Progress, pitfalls, and promiseCHINN, L. W; KROETZ, D. L.Clinical pharmacology and therapeutics. 2007, Vol 81, Num 2, pp 265-269, issn 0009-9236, 5 p.Article

Human 3'-phosphoadenosine 5'-phosphosulfate synthetase 2 (PAPSS2) pharmacogenetics: gene resequencing, genetic polymorphisms and functional characterization of variant allozymesXU, Zhen-Hua; FREIMUTH, Robert R; ECKLOFF, Bruce et al.Pharmacogenetics (London). 2002, Vol 12, Num 1, pp 11-21, issn 0960-314XArticle

Pharmacogenetic profiling might meet the challengeJOLOBE, Oscar M. P.Journal of internal medicine. 2011, Vol 270, Num 5, pp 494-495, issn 0954-6820, 2 p.Article

Enzymatic basis of the debrisoquine/sparteine-type genetic polymorphism of drug oxidation: characterization of bufuralol 1'-hydroxylation in liver microsomes of in vivo phenotyped carriers of the genetic deficiencyDAYER, P; KRONBACH, T; EICHELBAUM, M et al.Biochemical pharmacology. 1987, Vol 36, Num 23, pp 4145-4152, issn 0006-2952Article

Pharmacogenetics of opioidsSOMOGYI, Andrew A; BARRATT, Daniel T; COLLER, Janet K et al.Clinical pharmacology and therapeutics. 2007, Vol 81, Num 3, pp 429-444, issn 0009-9236, 16 p.Article

Pharmacogenetics: potential for individualized drug therapy through geneticsJOHNSON, Julie A.Trends in genetics (Regular ed.). 2003, Vol 19, Num 11, pp 660-666, issn 0168-9525, 7 p.Article

Les actualités sur la pharmacogénétiqueBECQUEMONT, Laurent.La Lettre du pharmacologue (Boulogne). 2013, Vol 27, Num 3, issn 0984-452X, 24 p.Serial Issue

Pharmacogenetics : From Bench to ByteSWEN, J. J; WILTING, I; KOOPMANS, R et al.Clinical pharmacology and therapeutics. 2008, Vol 83, Num 5, pp 781-787, issn 0009-9236, 7 p.Article

Pharmacogenetics : focus on pharmacodynamicsLINDPAINTNER, Klaus; FOOT, Elizabeth; CAULFIELD, Mark et al.International journal of pharmaceutical medicine. 2001, Vol 15, Num 2, pp 74-82, issn 1364-9027Article

Challenges in pharmacogeneticsCASCORBI, Ingolf; BRUHN, Oliver; WERK, Anneke N et al.European journal of clinical pharmacology. 2013, Vol 69, issn 0031-6970, S17-S23, SUP1Article

Pharmacosynthetics: Reimagining the pharmacogenetic approachFARRELL, Martilias S; ROTH, Bryan L.Brain research. 2013, Vol 1511, pp 6-20, issn 0006-8993, 15 p.Article

PHARMACOGENETICS: PART IGIBALDI, Milo.The Annals of pharmacotherapy. 2007, Vol 41, Num 12, pp 2042-2047, issn 1060-0280, 6 p.Article

ADRIS: The Adverse Drug Reactions Information schemeHUG, Hubert; BAGATTO, Dario; DANNECKER, Robert et al.Pharmacogenetics (London). 2003, Vol 13, Num 12, pp 767-772, issn 0960-314X, 6 p.Article

Validating and Using Pharmacogenomics: Joint IFCC-Roche Diagnostics Conference, Kyoto, Japan, 16-19 April 2000Clinical chemistry and laboratory medicine. 2000, Vol 38, Num 9, issn 1434-6621, 143 p.Conference Proceedings

Pharmacogénétique et rhumatologieDIEUDE, P; MICHOU, L; CORNELIS, F et al.L' Actualité rhumatologique. 2003, pp 311-320, issn 0065-1818, 10 p.Article

PHARMACOGENETICS: PART IIGIBALDI, Milo.The Annals of pharmacotherapy. 2007, Vol 41, Num 12, pp 2048-2054, issn 1060-0280, 7 p.Article

The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphineLÖTSCH, Jörn; SKARKE, Carsten; GRÖSCH, Sabine et al.Pharmacogenetics (London). 2002, Vol 12, Num 1, pp 3-9, issn 0960-314XArticle

Accelerated publication the legacy of pharmacogenetics and potential applicationsWEBER, Wendell W.Mutation research. 2001, Vol 479, Num 1-2, pp 1-18, issn 0027-5107Article

Developing Pharmacogenetic Evidence Throughout Clinical DevelopmentBURNS, D. K.Clinical pharmacology and therapeutics. 2010, Vol 88, Num 6, pp 867-870, issn 0009-9236, 4 p.Article

Genotyping and haplotyping of CYP2C19 functional alleles on thin-film biosensor chipsNAKAMOTO, Kaori; KIDD, Judith R; JENISON, Robert D et al.Pharmacogenetics and genomics (Print). 2007, Vol 17, Num 2, pp 103-114, issn 1744-6872, 12 p.Article

  • Page / 197